4: Statement of changes in beneficial ownership of securities-Officer Cislini Jeff
144: Notice of proposed sale of securities pursuant to Rule 144
S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers
10-Q: Quarterly report
8-K: Revolution Medicines Reports First Quarter 2024 Financial Results and Update on Corporate Progress
4: Statement of changes in beneficial ownership of securities-Officer Anders Jack
144: Notice of proposed sale of securities pursuant to Rule 144
UPLOAD: Others
ARS: Annual Report to Security Holders
DEFA14A: Others
DEF 14A: Definitive information statements
CORRESP: CORRESP
Revolution Medicines | 4: Statement of changes in beneficial ownership of securities-Officer GOLDSMITH MARK A
Revolution Medicines | 4: Statement of changes in beneficial ownership of securities-Director Patel Sushil
Revolution Medicines | 144: Notice of proposed sale of securities pursuant to Rule 144
Revolution Medicines | 144: Notice of proposed sale of securities pursuant to Rule 144
Revolution Medicines | 144: Notice of proposed sale of securities pursuant to Rule 144
Revolution Medicines | 144: Notice of proposed sale of securities pursuant to Rule 144
UPLOAD: Others
Revolution Medicines | 3: Initial statement of beneficial ownership of securities-Officer Wei Lin
No Data